In situ nucleic acid hybridization was tested for the ability to detect bluetongue virus (BTV) nucleic acids in blood mononuclear cells. A standard protocol was devised and applied to the demonstration of BTV genetic sequences in cultured bovine mononuclear cells that had been infected in vitro. In situ hybridization using biotinylated single-stranded RNA probes, in the presence of 50% formamide at 50 C, demonstrated an intense, positive signal in 0.00l-0.01% of the BTV-infected cultured mononuclear cells. The protocol was applied to isolated mononuclear cells from an experimentally infected heifer. No infected cells were observed by this method, although the blood specimens were obtained during peak viremia.
Bluetongue virus (BTV) of the genus Orbivirus in the family Reoviridae is responsible for acute clinical disease and multiple reproductive syndromes in domestic and wild ruminants. This viral serogroup has a doublestranded (ds) RNA genome consisting of 10 segments ranging in size from 0.5 × 10 6 to 2.8 × 10 6 daltons, 23 which codes for at least 10 unique structural polypeptides. 9, 13, 18 Cloning of BTV genome segments has been reported by several authors, and these DNA clones have been used for nucleotide sequencing 5, 6, 8, 12, 15, 26 and as probes for identification of BTV nucleic acids.
Numerous reports have focused on the use of hybridization methods for the detection of BTV. Most of the reports have described and defined the use of cloned BTV genome segments as probes against dot blot samples of nucleic acids from infected cell cultures. 3, 11, 19, 20 In situ hybridization with BTV-specific probes has also been demonstrated. 1, 17, 24 In an early short communication, in situ hybridization to white blood cells from an experimentally BTV-infected sheep was reported using a horseradish peroxidase marker. 17 However, the reliability of this technique has not been confirmed. In situ hybridization to tissues from BTVinfected embryonated chickens eggs has been recently reported, with the suggestion that this may serve as a useful method for BTV diagnosis. 24 A rapid solution hybridization assay for use on BTV-infected cell cultures has also been reported that employs single-stranded (ss) RNA probes rather than double-stranded DNA probes, as reported in the other protocols. 2 Although dissection of the BTV genome may ultimately lead to a better understanding of the taxonomy of BTV and related orbiviruses, for now most attempts appear to be directed at using cloned BTV genomic probes to emulate the serologically defined classifications. This is a reasonable approach if the critical epitopes underlying serogroup and serotype specificity are based on the primary structure of the viral proteins and, therefore, can be expected to be represented, more or less, directly in the viral genome. However, the specificity of epitopes based on higher orders of polypeptide structure may not be readily emulated by nucleotide sequences cloned from the genome. This has been demonstrated in experiments that have tested the specificity of selected BTV nucleic acid probes. 3, 11, 20 In 1 report, a BTV-17-specific probe derived from genome segment 2, which codes for major serotype-specific epitopes, hybridized solely to BTV-17 field isolates and failed to hybridize to multiple field isolates of the other US BTV serotypes. 3 Group-specific hybridization patterns have also been reported. 2, 4, 8, 11, 16, 17 Existing evidence indicates that specific nucleic acid probes can be generated from cloned BTV nucleic acid sequences. The objective of this study was to determine whether these probes are useful for the detection and identification of BTV isolates from blood. With the exception of 1 early report using in situ hybridization, the application of nucleic acid hybridization assays for the detection of BTV within blood cells has not been reported.
Probes

Materials and methods
The T3 and T7 RNA polymerase-derived transcripts (antisense and positive sense probes, respectively) from recom-303 binant plasmid pTSD11-6 were used for the following assays. The original recombinant plasmid was derived from a 1,300base pair clone of segment 6 of the US prototype strain of 4 which was subcloned into an RNA transcription vector. 2 Probe molecules were synthesized by a standard technique as previously described 2 and labeled by incorporation of radiolabeled and biotinylated nucleotides during in vitro transcription. The radiolabeled nucleotide was used to monitor the transcription reaction and to infer the incorporation of biotinylated nucleotide.
Preparation of cultured cells
The method of cell cultivation system for studying the interaction of BTV with blood mononuclear cells has been reported. 22 Mononuclear cells were isolated from the buffy coat of BTV-free bovine blood samples. Buffy coat cells were diluted 1:2 in phosphate-buffered saline (PBS), pH 7.4, and layered onto Histopaque. a The isolated mononuclear cells were cultured at 2 × 10 6 /ml in Dulbecco's minimal essential medium (MEM) with 20% fetal bovine serum, 100 units/ml of recombinant human interleukin-2, and 1 µg/ml concanavalin A. Cells were suspended at a concentration of 2 × 10 6 cells/ml Dulbecco's MEM and infected with BTV-17 at a multiplicity of infection of 1 by adsorption at 37 C for 2 hr. Following adsorption, cells were transferred to tissue culture flasks. At 24 and 48 hr postinfection, cells were monitored by cytospin sampling and viability counts. Infected cultures were assayed on Vero cell cultures to verify the replication of virus. Mononuclear cells used for in situ hybridization experiments were drawn from cultures with productive BTV infections exceeding 48 hr.
Preparation of cells from infected animal
Prior to experimental infection with BTV, the negative BTV status of an 18-mo-old heifer was confirmed by agar gel immunodiffusion after housing the animal at the university animal resources facility. The animal was inoculated with 8 × 10 8 plaque-forming units (PFU) of BTV-11, 50% of the dose given subcutaneously and 50% of the dose intravascularly. Blood from the heifer was sampled on a daily basis and prepared for virologic and clinical assays. Mononuclear cells were isolated on gradients, b washed with PBS, counted, and deposited onto glass microscope slides with a cytospin apparatus (3 × 10 5 cells/slide) for the in situ experiments. Aliquots of blood were centrifuged, and the blood cells were washed with sterile PBS for storage at 4 C. Samples of washed blood cells were assayed for the presence of virus by recovery on cell cultures. Viremia was confirmed in the heifer and titered by inoculation of 10-fold serially diluted sonicated blood samples onto Vero cell monolayers as described. 21
In situ hybridization
In situ hybridization of fresh and cultured mononuclear cells followed a procedure determined earlier. 1 Cells isolated from an experimentally infected heifer through peak viremia and cultured bovine mononuclear cells infected in vitro were assayed by this method. The mononuclear cells were applied to slides ( 3 × 10 5 cells/slide) using a cytospin apparatus. Cells were fixed with buffered 4% paraformaldehyde and stored in 70% ethanol until used.
The preparation of the slides was modified to follow a protocol using RNA probes. 10 Following the initial ethanol dehydration step, the slides were rehydrated in PBS with 5 mM MgCl 2 . The slides were acetylated, rinsed in 2 × standard saline citrate (SSC) (1 × SSC = 150 mM NaCl, 15 mM sodium citrate), and incubated in a solution of 100 mM glycine and 100 mM Tris-HCl (pH 7.9). The slides were prehybridized in 2 × SSC containing 50% formamide for 30 min prior to the application of the probe solutions.
The hybridization solution contained 5 µg/ml biotinylated ssRNA probe. The hybridization medium consisted of 5% polyethylene glycol, 300 mM NaCl, 10 mM HEPES (pH 7.4), 1 mM ethylenediaminetetraacetic acid, 200 µg/ml denatured salmon testes DNA, 20 mM vanadyl-ribonucleoside complexes, and 50% formamide. After application of 50 µ1 of heat-denatured probe solutions per slide, the slides were sealed with coverslips and rubber cement. Samples were hybridized with and without prior heat denaturation of the cells. Heatdenatured slides were incubated above a boiling water bath for 20 min prior to being placed in the hybridization incubator. Slides were incubated at 50 C overnight for at least 14 hr.
After the hybridization incubation, the coverslips were removed and the excess probe solution was removed by rinsing the slides with 2 × SSC at 37 C for 10 min. The posthybridization washes consisted of the following series: (1) 50% formamide, 2 × SSC at 50 C for 15 min; (2) 2 × SSC at 37 C for 15 min; (3) overlay slides treated with RNA probes with 20 µg/ml RNAse A and 20 units/ml RNAse T1 in 2 × SSC at 37 C for 1 hr; (4) repeat step (1) for a 30-min incubation; (5) repeat step (2) for a 30-min incubation. Following these washes, the slides were dehydrated in an ethanol series containing 300 mM ammonium acetate. The slides were rehydrated in Tris-buffered saline (TBS = 100 mM Tris-HCl, pH 7.5, and 150 mM NaCl) and covered with a blocking solution containing 3% bovine serum albumin and 0.05% Tween-20 in TBS for 1 hr at room temperature. The blocking solution was blotted off the slides and replaced with a 1:250 dilution of a commercial biotin detection reagent consisting of a streptavidin-alkaline phosphatase conjugate. c The detection reagent was diluted with 0.05% Tween-20 in TBS, layered onto the slides, and incubated for 15 min at room temperature. The slides were washed 3 times for 10 min each with 0.5% Tween-20 in TBS at room temperature. The slides were then equilibrated for 5 min in 2 changes of detection buffer containing 100 mM Tris-HC1 (pH 9.8), 100 mM NaCl, and 50 mM MgCl. The slides were finally covered with the substrate solution containing 330 µg/ml nitroblue tetrazolium and 167 µg/ml 5-bromo-4-chloro-3-indolylphosphate in detection buffer. Positive detection of biotinylated probe molecules hybridized to the slides yielded a blue precipitate that developed in approximately 15 min to 2 hr. The chromogenic reaction was stopped by washing the slides with water and permitting the slides to air dry.
Results
Without prior heat denaturation of target sequences, in situ hybridization using biotinylated T3 RNA transcripts as anti-sense probe molecules on cultured mononuclear cells infected in vitro with BTV resulted in scattered cells with positive cytoplasmic staining; the number of positive cells per cytospin ranged from 0.001% to 0.01% of the cells on the slides. Figure 1 illustrates 2 microscopic fields containing positively labeled cells. No stained cells were evident from control uninfected mononuclear cell cultures. Parallel slides probed with T7 RNA transcripts (positive sense) yielded negative results, suggesting the T3 RNA probes were detecting productively infected cultured mononuclear cells. Heat denaturation of the cytospin preparations did not significantly enhance the signal with either probe, but low levels of specific hybridization signal may have been obscured by an increase in background staining.
The same protocol and T3 RNA transcript probe that yielded strong positive cellular hybridization signals on infected Vero cells and cultured bovine mononuclear cells failed to yield a positive signal in fresh blood mononuclear cells from an experimentally infected viremic heifer. Titration on Vero cells of a corresponding blood sample from this animal demonstrated a titer of 1-2 × 10 4 PFU/ml whole blood.
Discussion
This study describes the limitations of an in situ hybridization protocol for the detection of BTV in blood mononuclear cells. The only unequivocal results were demonstrated on cultured bovine mononuclear cells that had been infected in vitro. In these assays, only 0.001-0.01% of the cells generated a positive signal, which, based on the nature of the probe and the hybridization conditions, is presumably linked to the presence of a productive infection in this subpopulation of cells. The relationship between in situ signal intensity and the presence of viral messenger (m) RNA has been remarked upon in earlier reports. Researchers using ssRNA probes for canine distemper virus (CDV) have demonstrated a marked increase in signal when the ssRNA probe is complementary for the viral mRNA sequences as compared to the much lower signal achieved with the complementary positive sense RNA probe, which detects only copies of the CDV negative sense genomic RNA. 14 In a study involving cytomegalovirus (a DNA virus) hybridization signal was markedly reduced when sections were pretreated with ribonuclease, eliminating viral mRNA sequences. 7 No positive signal was generated when the same protocol and probe were applied to freshly isolated blood mononuclear cells from a viremic heifer. This failure to identify BTV in the blood specimen contrasts with an earlier report of positive detection of bluetongue virus in white blood cells within blood smears from infected sheep. l7 Assuming that the hybridization protocol, which has performed adequately on Vero cultures 1 and on cultured blood mononuclear cells (as demonstrated here), is equally appropriate for freshly isolated blood mononuclear cells, this finding appears to indicate a lack of target sequences. This condition may be due to the lack of a productive infection within the examined cell population or loss of a significant portion of the viral ssRNA component. Although in our experiments the isolated mononuclear cells at 7-9 days postinfection represented a peak viremia of l-2 × 10 4 PFU/ml whole blood, it is possible that the presence of productively infected mononuclear cells had significantly declined by this time. In another study, BTV was not isolated from mononuclear cells after 1 week postinfection, whereas positive isolation of BTV from erythrocytes continued until 35 days postinfection. 25 Furthermore, the presence of a nonstructural BTV protein was observed by immunofluorescence in approximately 0.002% of blood mononuclear cells isolated from an experimentally infected calf after 1 week of infection. However, at 9 days postinfection no positive cells were identified. 25 The lack of positive signal in the blood mononuclear cells may have also been the result of degradation of the ssRNA component in cells harboring a productive would be successful for only a fraction of the viremic infection of BTV. Single-stranded RNA is notoriously phase of infection. To extend this calculation, to achieve labile and may have been degraded by intracellular the point at which the hybridization assay would offer ribonucleases during the preparation of the mononu-greater sensitivity than the infectious unit assay would clear cell fraction from whole blood. Although care require an infectivity to particle ratio of > 1:10 7 . The was taken to avoid exogenous ribonuclease contamipresence of noninfectious or degenerate BTV particles nation, the majority of reagents available for inhibiting at this concentration in blood has not been observed ribonuclease activity either require or lead to the reand is considered unlikely. In practice, attempts by 1 lease of RNA from cells and, consequently, were not of us (C.A.D.) to detect BTV RNA extracted from incorporated into this protocol.
viremic whole blood have not been successful. 1 
Regardless of the positive signals generated by in
Despite the failure of the in situ nucleic acid hysitu hybridization of cultured mononuclear cells, it does bridization techniques to detect BTV in blood, nucleic not appear that our in situ hybridization procedure is acid hybridization assays in general have some utility suitably reliable for the detection of BTV directly in for detecting BTV following initial virologic isolation, mononuclear cells from clinical blood samples. The and with an appropriate battery of probes this techsuccess of the technique appears to depend on the presnique might supplant current serologic-based characence of a productive infection leading to the synthesis terization of viral isolates. 3 The use of nucleic acid of sufficient levels of positive sense viral ssRNA comprobes to confirm an isolate as a member of the BTV plementary to the probe. Because of either the transient group and to classify the virus with respect to serotype nature of productive infection within blood mono-may minimize the cross-reactions seen with neutralizanuclear cells or the degradation of labile viral RNA tion assays and the time required to type virus isolates. species, sufficient levels of specific target RNA molecules for detection are liable to be, at best, inconsistent Furthermore, nucleic acid probes represent uniform and stable reagents unlike many of the polyclonal anwithin mononuclear cells. tisera currently used for BTV classification. The lack of a consistent productive infection within blood cells of BTV-viremic animals has great signifi-Acknowledgements cance to the application of all hybridization protocols (e.g., in situ, dot blot) for the direct detection of BTV in blood specimens for diagnostic purposes. Infectious BTV particles appear to associate with the different blood cell types at similar concentrations per cell. Consequently, without the presence of a productive infection in a given leukocyte population, there is no advantage, with regard to target viral RNA concentrations, to selecting any cellular fraction over whole blood. Without a productive infection to enhance the number of BTV genome copies, the amount of infectious BTV In previous work to establish the sensitivity of a dot blot hybridization procedure using the same probe described in these experiments, a practical sensitivity threshold of 10 -11 g of target molecules was obtained. 1 With a routine detection threshold of 10 pg, an assay using probe that detects a 1,300-base sequence would require the extraction and 100% recovery of RNA from approximately 1.4 × 10 7 BTV particles. Based on an infectivity to particle ratio of 1:1,000, a titer of 10 4 infectious units/ml would be necessary to achieve the threshold limit of BTV particles within a 1-ml sample of blood. This also assumes an unlikely 100% recovery of viral RNA. This theoretical manipulation suggests that a standard hybridization assay based on detection of extracted BTV genomic RNA from blood samples
